Sun Pharma sells one of its plants in the US

Sun Pharma (File) Sun Pharmaceutical Industries Ltd facility in Chennai

Drug maker Sun Pharmaceutical Industries Ltd on Monday said it is selling off one of its plants in the US for an undisclosed sum.

In a statement, Sun Pharma said as a part of its manufacturing consolidation in the US, one of its wholly-owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc. (Nostrum) for the divestment of the Bryan (Ohio) unit.

"As a part of the agreement, the Sun Pharma subsidiary has divested this unit as a going concern along with the employees and related products to Nostrum," the statement said.

This browser settings will not support to add bookmarks programmatically. Please press Ctrl+D or change settings to bookmark this page.
The Week

Get the full story

You can subscribe the week e- magazine to read the entire article. Available package details are listed.

Topics : #medical

Related Reading

    Show more